Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies AgainstStaphylococcus AureusExploitingIn VitroInformation-Reference-Cited by-同舟云学术

Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies AgainstStaphylococcus AureusExploitingIn VitroInformation

Published:2017-07-13 Issue:8 Volume:6 Page:512-522
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Wicha SG¹,Huisinga W²,Kloft C¹

Affiliation:

1. Department of Clinical Pharmacy and Biochemistry; Institute of Pharmacy, Freie Universitaet Berlin; Berlin Germany

2. Institute of Mathematics, University of Potsdam; Potsdam-Golm Germany

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Reference47 articles.

1. WHO Antimicrobial Resistance Global Report on Surveillance http://www.who.int/drugresistance/documents/surveillancereport/en 2014

2. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study;Wunderink;Clin. Infect. Dis.,2012

3. 2012 http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/table_reports.aspx

4. Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs;Nielsen;Pharmacol. Rev.,2013

5. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization;Nielsen;Antimicrob. Agents Chemother.,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards clinically relevant dose ratios for Cabamiquine and Pyronaridine combination using P. falciparum field isolate data;Nature Communications;2024-09-03

2. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

3. Model‐based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug‐resistant tuberculosis;British Journal of Clinical Pharmacology;2023-10-26

4. Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance;Antimicrobial Agents and Chemotherapy;2023-08-17

5. PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris;CPT: Pharmacometrics & Systems Pharmacology;2023-03-13